Impact of the COVID-19 Pandemic on Cancer Clinical Trials

被引：0

作者：

Judy C. Boughey

Rebecca A. Snyder

Olga Kantor

Linda Zheng

Akhil Chawla

Toan T. Nguyen

Shauna L. Hillman

Olwen M. Hahn

Sumithra J. Mandrekar

Christina L. Roland

机构：

[1] Mayo Clinic,Department of Surgery

[2] East Carolina University Brody School of Medicine,Division of Surgical Oncology

[3] Brigham and Women’s Hospital,Division of Breast Surgery, Department of Surgery

[4] American College of Surgeons Cancer Research Program,Division of Surgical Oncology, Department of Surgery, Northwestern Medicine Regional Medical Group

[5] Northwestern University Feinberg School of Medicine,Department of Health Sciences Research, Alliance Statistics and Data Management Center

[6] Lakeland Regional Health,Alliance Protocol Operations Office

[7] Mayo Clinic,Department of Surgical Oncology

[8] University of Chicago,undefined

[9] University of Texas MD Anderson Cancer Center,undefined

来源：

Annals of Surgical Oncology | 2021年 / 28卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The COVID-19 pandemic has had widespread impact on healthcare, resulting in modifications to how we perform cancer research, including clinical trials for cancer. The impact of some healthcare workers and study coordinators working remotely and patients minimizing visits to medical facilities impacted clinical trial participation. Clinical trial accrual dropped at the onset of the pandemic, with improvement over time. Adjustments were made to some trial protocols, allowing telephone or video-enabled consent. Certain study activities were permitted to be performed by local healthcare providers or at local laboratories to maximize patients’ ability to continue on study during these challenging times. We discuss the impact of COVID-19 on cancer clinical trials and changes at the local, cooperative group, and national level.

引用

页码：7311 / 7316

页数：5

共 36 条

[1]

Waterhouse DM(2020)Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology survey JCO Oncol Pract. 16 417-421

[2]

Harvey RD(2020)Impact of COVID-19 on oncology clinical trials Nat Rev Drug Discov. 19 376-377

[3]

Hurley P(2020)Impact of the coronavirus disease 2019 (COVID-19) pandemic on imaging case volumes J Am Coll Radiol. 17 865-872

[4]

Upadhaya S(2016)Teleconsent: a novel approach to obtain informed consent for research Contemp Clin Trials Commun. 3 74-79

[5]

Yu JX(2020)Digital informed consent in a rural and low-income population JAMA Cardiol. 5 845-847

[6]

Oliva C(2020)Progression of COVID-19 from urban to rural areas in the united states: a spatiotemporal analysis of prevalence rates J Rural Health. 36 591-601

[7]

Hooton M(2021)Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review JCO Glob Oncol. 7 311-323

[8]

Hodge J(2020)The electronic health record as a clinical trials tool: opportunities and challenges Clin Trials. 17 237-242

[9]

Hubbard-Lucey VM(undefined)undefined undefined undefined undefined-undefined

[10]

Naidich JJ(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 4 →